Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
INmune Bio Inc
INMB
Healthcare
Biotechnology
INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. It has two therapeutic platforms: a Dominant-Negative Tumor Necrosis Factor Platform (DN-TNF, XPro, XPro1595 or pegipanermin) and a Natural Killer (NK or INKmune) platform. The DN-TNF product platform utilizes dominant-negative technology to...
selectively neutralize soluble TNF, a key driver of innate immune dysfunction and a mechanistic driver of many diseases. DN-TNF product candidates are in clinical trials to determine if they can treat cancer (INB03) Mild Alzheimer's disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The NK Cell Priming Platform includes INKmune developed to prime a patient's NK cells to eliminate minimal residual disease in patients with cancer. Its product platforms utilize a precision medicine approach for the treatment of hematologic and solid tumor malignancies, and chronic inflammation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INMB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Oct 24, 2024 5:56pm
INMB XPro™ Promotes Remyelination
https://us15.campaign-archive.com/?e=1c52cd69f7&u=4a549c7aea3073da1e942d0ce&id=9f6b228d23
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Sep 30, 2024 8:13am
INMB completes phase two enrollment
https://us15.campaign-archive.com/?e=1c52cd69f7&u=4a549c7aea3073da1e942d0ce&id=5cb6aa3bde
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 09, 2024 4:05pm
New Press Release - INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
Company to Host Conference Call Today, May 9, at 4:30pm ET BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 07, 2024 8:00am
New Press Release - INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
Management to host conference call and webcast at 4:30 pm ET on that dayBoca Raton, Florida, May 07, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight...
read article.
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Apr 30, 2024 8:13am
INMB Provides Update on Two Patients from the P1A with AD
Very good news! https://mail.google.com/mail/u/0/#inbox/FMfcgzGxStxShvDQGLmpNvjKCBszgRhR
(38)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on Apr 29, 2024 10:37am
RE:RE:RE:When the Price of (INMB) Talks, People Listen
Can e reach the market of ibrx? Maybe not this year, but certainly possible 2-3 years out.
(38)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on Apr 29, 2024 8:30am
RE:RE:When the Price of (INMB) Talks, People Listen
More encouraging new, with multiple fronts it's going to be a busy year.
(38)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on Apr 28, 2024 6:11pm
RE:When the Price of (INMB) Talks, People Listen
Lots of positive news looking forward, very low float, no debt, long runway. Like the risk reward.
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 22, 2024 2:00pm
When the Price of (INMB) Talks, People Listen
Breaking News: $INMB When the Price of (INMB) Talks, People Listen2024-04-22 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology
...more
(38)
•••
Teccing
X
View Profile
View Bullboard History
Comment by
Teccing
on Feb 14, 2024 9:50pm
RE:FDA LIFT-OFF
Loving the future of inmb, enjoying the ride
(38)
•••
Teccing
X
View Profile
View Bullboard History
Post by
Teccing
on Feb 06, 2024 9:25pm
FDA LIFT-OFF
Finally approved, should a exciting year a head, with multiple site trials coming do.
(38)
•••
Teccing
X
View Profile
View Bullboard History
Post by
Teccing
on Jan 02, 2024 1:23pm
Prostate cancer
Praying for successful treatment, and hope for men who are battling this disease
(52)
•••
0checker
X
View Profile
View Bullboard History
Comment by
0checker
on Sep 09, 2021 10:58pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just the beginning
https://www.inmunebio.com/index.php/en/news-2/2021/468-muneioncnnouncesiomarkerataemonstratingtha20210825 " INmune Bio, Inc. Announces Biomarker Data Demonstrating that the First Patient
...more
(52)
•••
0checker
X
View Profile
View Bullboard History
Comment by
0checker
on Sep 05, 2021 10:09am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just the beginning
https://www.inmunebio.com/images/pdf/Presentation/2021/INMB_non-con_corp_August_1.pdf
(52)
•••
0checker
X
View Profile
View Bullboard History
Comment by
0checker
on Sep 05, 2021 9:07am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Just the beginning
https://twresearchgroup.com/2021/08/inkmune-induces-memory-like-nk-cells-this-is-a-very-big-deal/
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >